Literature DB >> 14697450

A modified relocatable stereotactic frame for irradiation of eye melanoma: design and evaluation of treatment accuracy.

Karin Muller1, Peter J C M Nowak, Grégorius P M Luyten, Johannes P Marijnissen, Connie de Pan, Peter Levendag.   

Abstract

PURPOSE: To describe a reliable, patient-friendly relocatable stereotactic frame for irradiation of eye melanoma and to evaluate the repositioning accuracy of the stereotactic treatment. METHODS AND MATERIALS: An extra construction with a blinking light and a camera is attached to a noninvasive relocatable Gill-Thomas-Cosman stereotactic frame. The position of the blinking light is in front of the unaffected eye and can be adjusted to achieve an optimal position for irradiation. The position of the diseased eye is monitored with a small camera. A planning CT scan is performed with the affected eye in treatment position and is matched with an MR scan to improve the accuracy of the delineation of the tumor. Both the translation and rotation of the affected eye are calculated by comparing the planning CT scan with a control CT scan, performed after the radiation therapy is completed.
RESULTS: Nineteen irradiated eye melanoma patients were analyzed. All patients received 5 fractions of 10 Gy within 5 days. The depth-confirmation helmet measurements of the day-to-day treatment position of the skull within the Gill-Thomas-Cosman frame were analyzed in the anteroposterior, lateral, and vertical directions and were 0.1 +/- 0.3, 0.0 +/- 0.2, and 0.2 +/- 0.2 mm (mean +/- SD), respectively. The average translations of the eye on the planning and control CT scan were 0.1 +/- 0.3 mm, 0.1 +/- 0.4, and 0.1 +/- 0.5 mm, respectively. The median rotation of the diseased eye was 8.3 degrees.
CONCLUSIONS: The described Rotterdam eye fixation system turned out to be a feasible, reliable, and patient-friendly system.

Entities:  

Mesh:

Year:  2004        PMID: 14697450     DOI: 10.1016/j.ijrobp.2003.08.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Clinical results of a pilot study on stereovision-guided stereotactic radiotherapy and intensity modulated radiotherapy.

Authors:  Shidong Li; Lawrence R Kleinberg; Daniele Rigamonti; Moody D Wharam; Abdul Rashid; Juan Jackson; David Djajaputra; Shenjen He; Tunisia Creasey; Theodore L DeWeese
Journal:  Technol Cancer Res Treat       Date:  2010-12

2.  Feasibility study of a non-invasive eye fixation and monitoring device using a right-angle prism mirror for intensity-modulated radiotherapy for choroidal melanoma.

Authors:  Toshihiko Inoue; Norihisa Masai; Hiroya Shiomi; Ryoong-Jin Oh; Kenji Uemoto; Noriyasu Hashida
Journal:  J Radiat Res       Date:  2017-05-01       Impact factor: 2.724

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.